Deshane JS - Search Results

1

Elevated levels of NO are localized to distal airways in asthma.

Anderson JT, Zeng M, Li Q, Stapley R, Moore DR 2nd, Chenna B, Fineberg N, Zmijewski J, Eltoum IE, Siegal GP, Gaggar A, Barnes S, Velu SE, Thannickal VJ, Abraham E, Patel RP, Lancaster JR Jr, Chaplin DD, Dransfield MT, Deshane JS. Anderson JT, et al. Among authors: deshane js. Free Radic Biol Med. 2011 Jun 1;50(11):1679-88. doi: 10.1016/j.freeradbiomed.2011.03.015. Epub 2011 Mar 16. Free Radic Biol Med. 2011. PMID: 21419218 Free PMC article.

2

NK and NKT cells in the pathogenesis of Hidradenitis suppurativa: Novel therapeutic strategy through targeting of CD2.

Kashyap MP, Mishra B, Sinha R, Jin L, Kumar N, Goliwas KF, Deshane J, Elewski BE, Elmets CA, Athar M, Shahid Mukhtar M, Raman C. Kashyap MP, et al. bioRxiv [Preprint]. 2023 Nov 2:2023.10.31.565057. doi: 10.1101/2023.10.31.565057. bioRxiv. 2023. PMID: 37961206 Free PMC article. Preprint.

3

Targeted eradication of ovarian cancer mediated by intracellular expression of anti-erbB-2 single-chain antibody.

Deshane J, Cabrera G, Grim JE, Siegal GP, Pike J, Alvarez RD, Curiel DT. Deshane J, et al. Gynecol Oncol. 1995 Oct;59(1):8-14. doi: 10.1006/gyno.1995.1260. Gynecol Oncol. 1995. PMID: 7557620

4

Intracellular single-chain antibody directed against erbB2 down-regulates cell surface erbB2 and exhibits a selective anti-proliferative effect in erbB2 overexpressing cancer cell lines.

Deshane J, Loechel F, Conry RM, Siegal GP, King CR, Curiel DT. Deshane J, et al. Gene Ther. 1994 Sep;1(5):332-7. Gene Ther. 1994. PMID: 7584099

5

Targeted tumor killing via an intracellular antibody against erbB-2.

Deshane J, Siegal GP, Alvarez RD, Wang MH, Feng M, Cabrera G, Liu T, Kay M, Curiel DT. Deshane J, et al. J Clin Invest. 1995 Dec;96(6):2980-9. doi: 10.1172/JCI118370. J Clin Invest. 1995. PMID: 8675670 Free PMC article.

6

Intracellular antibody against erbB-2 mediates targeted tumor cell eradication by apoptosis.

Deshane J, Grim J, Loechel S, Siegal GP, Alvarez RD, Curiel DT. Deshane J, et al. Cancer Gene Ther. 1996 Mar-Apr;3(2):89-98. Cancer Gene Ther. 1996. PMID: 8729907

7

Gene therapy and ovarian cancer: a review.

Barnes MN, Deshane JS, Rosenfeld M, Siegal GP, Curiel DT, Alvarez RD. Barnes MN, et al. Among authors: deshane js. Obstet Gynecol. 1997 Jan;89(1):145-55. doi: 10.1016/s0029-7844(96)00296-7. Obstet Gynecol. 1997. PMID: 8990458 Review.

8

Transductional efficacy and safety of an intraperitoneally delivered adenovirus encoding an anti-erbB-2 intracellular single-chain antibody for ovarian cancer gene therapy.

Deshane J, Siegal GP, Wang M, Wright M, Bucy RP, Alvarez RD, Curiel DT. Deshane J, et al. Gynecol Oncol. 1997 Mar;64(3):378-85. doi: 10.1006/gyno.1996.4566. Gynecol Oncol. 1997. PMID: 9062138

9

An intracellular anti-erbB-2 single-chain antibody is specifically cytotoxic to human breast carcinoma cells overexpressing erbB-2.

Wright M, Grim J, Deshane J, Kim M, Strong TV, Siegal GP, Curiel DT. Wright M, et al. Gene Ther. 1997 Apr;4(4):317-22. doi: 10.1038/sj.gt.3300372. Gene Ther. 1997. PMID: 9176517

10

The level of erbB2 expression predicts sensitivity to the cytotoxic effects of an intracellular anti-erbB2 sFv.

Grim J, Deshane J, Siegal GP, Alvarez RD, DiFiore P, Curiel DT. Grim J, et al. J Mol Med (Berl). 1998 May;76(6):451-8. doi: 10.1007/s001090050237. J Mol Med (Berl). 1998. PMID: 9625302

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

107 results

Search Page

Filters